Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study

Thomas N Williams1, Sophie Uyoga, Alex Macharia

  • 1Centre for Geographic Medicine Research-Coast, Kilifi, Kenya. twilliams@kilifi.kemri-wellcome.org

Lancet (London, England)
|September 15, 2009
PubMed

Insights

Children with sickle-cell anaemia in sub-Saharan Africa face a significantly higher risk of invasive bacterial diseases, particularly from Streptococcus pneumoniae and non-typhi Salmonella. Vaccination against these pathogens could greatly improve survival rates.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hematology

Background:

  • Sub-Saharan Africa faces high child mortality from sickle-cell anaemia, often before diagnosis.
  • Bacterial sepsis is a likely, yet poorly documented, cause of death in these children.
  • This study investigated the risk of invasive bacterial diseases in pediatric sickle-cell anaemia patients.

Purpose of the Study:

  • To assess the incidence and causative agents of invasive bacterial diseases in children with sickle-cell anaemia.
  • To determine the association between sickle-cell anaemia and bacteraemia.
  • To inform public health strategies, including vaccination, for improved child survival.

Main Methods:

  • A case-control study was conducted in rural Kenya.
  • Blood cultures were performed on children under 14 admitted to Kilifi District Hospital over a 10-year period.
  • Sickle-cell anaemia status was retrospectively determined for cases (bacteraemia) and controls.

Main Results:

  • 2157 episodes of bacteraemia were detected in 38,441 admissions (6%).
  • Children with sickle-cell anaemia had a significantly higher odds ratio (26.3) for bacteraemia.
  • Streptococcus pneumoniae, non-typhi Salmonella, and Haemophilus influenzae type b were the most common pathogens identified.

Conclusions:

  • The bacterial organisms causing bacteraemia in African children with sickle-cell anaemia are similar to those in developed countries.
  • Implementing conjugate vaccines for Streptococcus pneumoniae and Haemophilus influenzae type b in routine childhood immunisation programs could significantly enhance survival.
  • Targeted interventions are crucial for reducing mortality in children with sickle-cell anaemia.
Abstract